ZYME stock

Zymeworks Inc. Common Stock (ZYME) financials · rev $106.0M

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Zymeworks Inc. Common Stock (ZYME) rev $106.0M.

Cached annual income statement
LineFY2025FY2024
Revenue$106.0M$76.3M
Operating Income-$92.5M-$137.1M
Net Income-$81.1M-$122.7M
EPS (Diluted)-$1.08-$1.62
Cached annual balance sheet
LineFY2025FY2024
Total Assets$346.5M$463.1M
Current Assets$248.8M$300.5M
Cash & Equivalents$41.2M$66.1M
PP&E$15.5M$17.6M
Total Liabilities$78.0M$124.3M
Current Liabilities$42.3M$88.3M
Shareholders' Equity$268.5M$338.8M
Retained Earnings-$953.2M-$830.3M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$33.0M-$110.0M
CapEx$1.52M$1.99M
Investing Cash Flow$26.7M$38.8M
Financing Cash Flow-$18.6M-$20.5M
Net Change in Cash-$24.9M-$91.5M
Free Cash Flow-$34.5M-$112.0M
These statements as JSON? API free 100/day

FAQ

What is ZYME P/E and revenue?

Zymeworks Inc. Common Stock (ZYME) rev $106.0M.

What is ZYME revenue?

Zymeworks Inc. Common Stock last cached revenue is $106.0M (FY2025).

Is ZYME profitable?

Zymeworks Inc. Common Stock last cached net income is -$81.1M (FY2025).

What are ZYME total assets?

Zymeworks Inc. Common Stock last cached total assets are $346.5M (FY2025).

What is ZYME free cash flow?

Zymeworks Inc. Common Stock last cached free cash flow is -$34.5M (FY2025).

Not investment advice. Cached statements, not a live tape.